Nature Reviews Endocrinology

Papers
(The median citation count of Nature Reviews Endocrinology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Exposing skin to ultraviolet irradiation increases food intake in male individuals555
Timed high-fat diet feeding restores small bowel circadian rhythms523
Non-nutritive sweeteners — too sweet to be wholesome?491
Dexamethasone in patients with diabetes mellitus472
Exercise-induced plasma factors confer brain benefits331
CNOT6L regulates hepatokine expression319
The role of DNA damage in diabetic complications319
Immune cell population prevents weight regain318
Memory of obesity stored in adipocytes294
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations293
Author Correction: Adrenocortical stem cells in health and disease277
Limiting the use and misuse of liothyronine in hypothyroidism266
Effects of diet on atherosclerotic plaque development255
Thyroid function and iodine intake: global recommendations and relevant dietary trends216
The challenges of assessing adiposity in a clinical setting202
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead160
The gut microbiota in obesity and weight management: microbes as friends or foe?159
Type 2 diabetes mellitus in older adults: clinical considerations and management156
To fast or not to fast — that is the question153
Metformin reduces ageing adipose senescence149
Negative regulator of GDF15 signalling identified142
Ketosis improves muscle stem cell resilience132
Iron in adipocytes — a role in gut–adipose crosstalk132
Obesity phenotypes: explaining the unexplained126
Metabolite levels during the menstrual cycle121
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects118
The interactions between energy homeostasis and neurovascular plasticity114
mTORC1 is the central regulator in pancreatic β-cells114
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity113
Research in metabolic ageing — a tale of mice versus humans?113
The importance of human brown adipose tissue volume111
A pivotal year for NAFLD and NASH therapeutics110
Role for exosomes in insulin sensitivity109
Neurons in the diagonal band of Broca moderate food intake109
Patients’ insights into diabetes insipidus105
Steroid hormones as modulators of anti-tumoural immunity102
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy101
Novel therapies with precision mechanisms for type 2 diabetes mellitus100
Primary aldosteronism — a multidimensional syndrome98
One hundred years of insulin therapy95
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease95
A role for phosphocreatine in adipose inflammation90
Genetic risk scores improve prediction of obesity in survivors of childhood cancer89
Ketogenic modification of the liver proteome89
New role for bone marrow adipocytes in obesity88
Role of extracellular vesicles in β-cell failure87
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption87
Bone and muscle crosstalk in ageing and disease81
Luteal phase support in assisted reproductive technology77
A role for the kidney in metformin action76
Urocortin 3 function in glucose metabolism76
RalA links obesity and mitochondrial dysfunction75
The metabolic mythos of ketones73
Progress in islet transplantation is more important than ever73
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus72
Advances in basic biology and translation in islet research71
Stem-cell derived pancreatic endoderm cells in the treatment of T1DM70
Inflammation-induced adrenal dysfunction69
Targeting the incretin system in obesity and type 2 diabetes mellitus67
Endosomal trafficking in metabolic homeostasis and diseases66
Advances in incretin-based therapeutics for obesity62
Untangling the pathways of SDHx loss of function60
Tracing the biological roots of obesity resistance in humans58
Triggering puberty in primates: is it NPY?58
REG3G — a potential link between the intestinal microbiome and host physiology56
The metabolic benefits of exercise-induced hepatic autophagy55
Iatrogenic adrenal insufficiency in adults53
A multi-omics roadmap of β-cell failure in type 2 diabetes mellitus52
New insights into β-cell failure, regeneration and replacement52
Leptin–thyroid hormone axis affects energy use in muscle51
Potential downsides of calorie restriction51
Skeletal and extraskeletal disorders of biomineralization50
A global view of hypertensive disorders and diabetes mellitus during pregnancy48
Muscle VPS39 deficiency in people with T2DM46
Islet hormones at the intersection of glucose and amino acid metabolism46
Length of light exposure alters energy metabolism in mice45
HIF1α inhibition preserves β-cell function44
Potential role for follicular Treg cells in T1DM43
Unravelling umami-induced obesity43
Remission of T2DM requires early diagnosis and substantial weight reduction42
Vitamin D supplementation and fracture risk42
GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating42
From the perspective of a scientist with Cushing disease, what did not kill me made my science stronger40
Investigating the effects of artificial sweeteners40
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?39
Melatonin prevents diabetes mellitus-induced bone loss39
Obesity dysregulates a pituitary–liver axis through disruption of the unfolded protein response39
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?37
Lipid droplet biogenesis and functions in health and disease36
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice36
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus36
Sarcopenic obesity in older adults: a clinical overview35
Engineered Tregs prevent diabetes mellitus in mice35
Mitigating the environmental effects of healthcare: the role of the endocrinologist34
At the 2022 Congress on Obesity34
Role of bile acids in controlling satiety33
GnRH pulses affect ageing in male mice33
Variation in serotonin 2C receptor linked with obesity and behaviour33
Sertoli cell lysosomal dysfunction drives age-related testicular degeneration32
Targeting senescent cells in ageing-related endocrine diseases32
The glymphatic system as a nexus between obesity and neurological diseases31
Molecular transducers and the cardiometabolic benefits of exercise30
Energy intake at the intersection of the clock and ageing29
Growth hormone-releasing hormone and its analogues in health and disease27
Exercise in adults with type 1 diabetes mellitus27
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?27
Metformin and GDF15: where are we now?27
Exosomes as novel biomarkers in metabolic disease and obesity-related cancers26
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency25
Large study on hormone therapy for transgender youth provides reassurance amid treatment politicization25
Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities25
New genes associated with adult-onset obesity24
A protective role for insulin in acute pancreatitis24
The largest study of genetics of T1DM24
A mitochondrial trigger for beige adipocyte development23
GWAS gives insights into glucose regulation23
Mitochondria transported from adipocytes in extracellular vesicles23
Interventions in people newly diagnosed with type 1 diabetes mellitus22
Brown adipose tissue fights the battle against leukaemia22
Medically not yet explained symptoms in hypothyroidism21
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss19
Highlights from SfE BES 202119
Paracetamol use in pregnancy — caution over causal inference from available data19
The regulation of endocrine-disrupting chemicals to minimize their impact on health19
TIM4+ adipose tissue-resident macrophages: new modulators of adiposity19
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment18
Variation in metformin pharmacokinetics17
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia17
Metabolic effects of gender-affirming hormone therapy17
Sex differences in diabetic kidney disease explained17
SRC2 controls the refeeding response in mice17
Combination therapy increases human β-cell mass in vivo17
Masterful papers that broke open understanding of reproductive neuroendocrinology16
Knowledge in youth is wisdom in age: involving young people in research16
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia16
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus16
How COVID-19 disrupts glycometabolic control16
Glial control of neuronal function15
The complex effects of dietary restriction on longevity and health14
Highlights from ADA 82nd Scientific Sessions14
Environmental factors in declining human fertility14
New BAT–liver endocrine pathway via succinate14
FGF1 signalling cascade suppresses lipolysis14
A role for HDAC6 in leptin sensitivity14
An updated view on human neonatal thermogenesis13
Senescent immune cells promote skeletal ageing13
AcroBATics: how dying brown adipocytes trigger browning13
Bone fragility in type 2 diabetes mellitus: a lot left to explore13
Dysfunctional lipid metabolism in ageing muscle: effects on glucose tolerance13
Antioxidant liver myeloid cell population identified13
The study that pioneered islet isolation techniques12
Obesity induces epigenetic memory in innate immune cells12
Author Correction: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits12
Skeletal stem and progenitor cells in bone physiology, ageing and disease12
New variant for monogenic obesity11
Genomics suggest role for IGF1 resistance in T2DM11
CAMK1D required for ghrelin-mediated food intake11
Paracetamol use in pregnancy — neglecting context promotes misinterpretation11
Understanding the complexity of insulin resistance11
Endoscopic sleeve gastroplasty: safe and effective10
Targeting hyperglucagonaemia in T2DM10
The intersection between ghrelin, metabolism and circadian rhythms9
Adipocytes enter the cell cycle in obesity9
IL-17 has a role in whole-body homeostasis9
Current and future pharmacotherapies for obesity in children and adolescents9
Thyroid hormone action during development9
Thyroid dysfunction in COVID-199
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits9
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus9
Human stomach tissue as alternative source of insulin-producing cells8
Empowering early career researchers: academy-driven pathways to excellence8
The physiological role of β-cell heterogeneity in pancreatic islet function8
Pituitary stem cells: past, present and future perspectives8
Big data reveals a dominant link between education and diet quality8
Stem cells define adipose depot differences8
Weight stigma in healthcare settings is detrimental to health and must be eradicated8
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement8
Translational perspectives from TSHR, MCT8 and TRα research8
Metabolic and feeding adjustments during pregnancy8
The interplay between diabetes mellitus and menopause: clinical implications8
A transporter on the move7
Control loop designs in health and disease7
Deciphering the role of leptin in weight gain associated with anti-psychotic medications7
Reply to ‘The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults’7
Modelling human liver disease: from steatotic liver disease to MASH-HCC7
Adipocyte-derived exosomes drive cancer metastasis7
JNK at the helm: decoding obesity-driven insulin resistance7
Osteocalcin influences lifelong adrenal function7
Intricacies and obscurities of non-shivering thermogenesis7
How the WHIMS clinical trial shaped the future of women’s health research6
Brain–immune networks: a role for GLP1 receptor6
Adipose tissue lipolysis controlled by endothelial cells6
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer6
PCOS — a metabolic condition with health impacts on women and men6
Logic and mechanisms of metabolite signalling6
Glycogen involved in browning of adipocytes6
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?6
Obesity-associated ASB4 controls satiety6
Potential gut–brain mechanisms behind adverse mental health outcomes of bariatric surgery6
Bile acid species shows potential for NAFLD6
Endocrine effects of heat exposure and relevance to climate change6
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus6
Ghrelin’s effects on growth hormone release: to pulse or not to pulse?6
Succinate signalling regulates leptin production in adipocytes5
Cause of rare form of Cushing syndrome found5
Insulin receptor sets liver clock5
Optimising stem cells for diabetes mellitus therapy5
Exploring the functions of the myokine feimin5
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice5
Nonenzymatic prevention of insulin hyperresponsiveness by FBP15
A century of glucagon5
Health equity in endocrinology5
New treatment target for endometriosis5
The relationship between the gut microbiota and thyroid disorders5
Low brown adipose tissue activity linked to NAFLD5
Exerkines in health, resilience and disease5
Defining subpopulations of human adipose tissue progenitor cells5
The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults5
Brain insulin action in women5
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy5
Adrenal cysts: an emerging condition5
Oxytocin regulates adipose tissue lipolysis4
Consensus Statement on the definition and classification of metabolic hyperferritinaemia4
Genomic alterations in thyroid cancer: biological and clinical insights4
Cognitive function in T1DM improved by hybrid closed-loop insulin delivery4
Debunking the myths of intermittent fasting4
Early life factors that affect obesity and the need for complex solutions4
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus4
Emerging mechanisms of obesity-associated immune dysfunction4
Highlights from SfE BES 20234
Adipose tissue in communication: within and without4
Diet composition affects mitochondria trafficking in adipose tissue4
Autophagy in metabolic disease and ageing4
Follistatin linked to type 2 diabetes mellitus risk4
Ketogenic diet in cancer: insufficient stress response?4
Approval of teplizumab: implications for patients4
Glucose-lowering treatments and COVID-19 mortality in T2DM3
Macrophages support pancreatic development3
Engineering adipocytes for cancer treatment3
The launch of European Hormone Day and EUWIN3
The role of regulated necrosis in endocrine diseases3
Metabolic alliance: pharmacotherapy and exercise management of obesity3
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification3
GDF15 boosts muscle energy burn3
Sulfonylurea secondary failure mechanism identified3
CCN3 maintains bone density during lactation3
Promising findings in PTH replacement therapy trial3
Obesity induces systemic insulin resistance via endothelium-specific insulin receptor inhibition3
Inceptor loss in mice with obesity3
Mitochondrial and metabolic dysfunction in ageing and age-related diseases3
0.078945159912109